Form 4: HealthLynked CEO Michael Dent Acquires $150,000 in Convertible Notes
SEC Form 4 Filing
HealthLynked Corp's CEO, Michael Dent, through a trust, acquired $150,000 in 12% Convertible Notes on April 10, 2024.
Summary
- On April 10, 2024, Michael Dent, CEO of HealthLynked Corp, acquired $150,000 in 12% Convertible Notes.
- The notes are convertible into 2,599,653 shares of common stock at a conversion price of $0.0577.
- The notes were purchased by the Mary S. Dent Gifting Trust, for which Michael Dent serves as trustee.
- The notes are exercisable from April 10, 2024, and expire on October 10, 2024.
- The reported transaction excludes shares issuable upon conversion of accrued interest into common stock.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing related to insider trading. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about a transaction.
Industry Context
Form 4 filings are standard disclosures required by the SEC when company insiders, like CEOs and directors, trade their company's securities. This provides transparency to the market regarding insider activity.
Stakeholder Impact
- The purchase of convertible notes by the CEO's trust could be viewed positively by shareholders as it demonstrates confidence in the company's future.
Key Dates
| Date | Description |
|---|---|
| January 31, 2006 | Date of the Mary S. Dent Gifting Trust |
| April 10, 2024 | Date of transaction: Purchase of convertible notes |
| April 10, 2024 | Date the convertible notes become exercisable |
| October 10, 2024 | Expiration date of the convertible notes |
| April 12, 2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.